Glial Fibrillary Acidic Protein (GFAP) Autoimmunity in the Setting of Seropositive Rheumatoid Arthritis Treated With Etanercept

Kelsey M. Smith,Shreyasee Amin,Lyell K. Jones,Daniel H Lachance,Eoin P. Flanagan,Mark E. Jentoft,Orhun H. Kantarci

Glial Fibrillary Acidic Protein (GFAP) Autoimmunity in the Setting of Seropositive Rheumatoid Arthritis Treated With Etanercept

2019

Kelsey M. Smith
Shreyasee Amin
Lyell K. Jones
Daniel H Lachance
Eoin P. Flanagan
Mark E. Jentoft
Orhun H. Kantarci

Introduction:Glial fibrillary acidic protein (GFAP) immunoglobulin G is a recently discovered biomarker of an autoimmune central nervous system disorder characterized by a steroid-responsive meningoencephalomyelitis.Case Report:A 63-year-old man with rheumatoid arthritis on etanercept presented with

Keywords:

Glial fibrillary acidic protein
Autoimmunity
Etanercept
Diabetes mellitus
Seropositive rheumatoid arthritis
Physical therapy
Medicine
Immunology
Immunoglobulin G
Neuroimmunology
TNF inhibitor
Rheumatoid arthritis
Biomarker (medicine)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations